Abstract:Graphene quantum dot (GQD) integration into hydrogel matrices has become a viable approach for improving drug delivery and bioimaging in cancer treatment in recent years. Due to their distinct physicochemical characteristics, graphene quantum dots (GQDs) have attracted interest as adaptable nanomaterials for use in biomedicine. When incorporated into hydrogel frameworks, these nanomaterials exhibit enhanced stability, biocompatibility, and responsiveness to external stimuli. The synergistic pairing of hydrogels with GQDs has created new opportunities to tackle the problems related to drug delivery and bioimaging in cancer treatment. Bioimaging plays a pivotal role in the early detection and monitoring of cancer. GQD-based hydrogels, with their excellent photoluminescent properties, offer a superior platform for high-resolution imaging. The tunable fluorescence characteristics of GQDs enable real-time visualization of biological processes, facilitating precise diagnosis and monitoring of cancer progression. Moreover, the drug delivery landscape has been significantly transformed by GQD-based hydrogels. Because hydrogels are porous, therapeutic compounds may be placed into them and released under a controlled environment. The large surface area and distinct interactions of graphene quantum dots (GQDs) with medicinal molecules boost loading capacity and release dynamics, ultimately improving therapeutic efficacy. Moreover, GQD-based hydrogels' stimulus-responsiveness allows for on-demand medication release, which minimizes adverse effects and improves therapeutic outcomes. The ability of GQD-based hydrogels to specifically target certain cancer cells makes them notable. Functionalizing GQDs with targeting ligands minimizes off-target effects and delivers therapeutic payloads to cancer cells selectively. Combined with imaging capabilities, this tailored drug delivery creates a theranostic platform for customized cancer treatment. In this study, the most recent advancements in the synergistic use of GQD-based hydrogels are reviewed, with particular attention to the potential revolution these materials might bring to the area of cancer theranostics.

Liposome-integrated hydrogel hybrids: Promising platforms for cancer therapy and tissue regeneration

Nanoparticle-Hydrogel: A Hybrid Biomaterial System for Localized Drug Delivery

Multifunctional and Self-Healable Intelligent Hydrogels for Cancer Drug Delivery and Promoting Tissue Regeneration In Vivo

Nanostructure-reinforced multifunctional hydrogels for synergistic cancer therapy

Liposome–Hydrogel Composites for Controlled Drug Delivery Applications

Injectable hydrogels as emerging drug-delivery platforms for tumor therapy

Biomacromolecular hydrogel scaffolds from microfluidics for cancer therapy: A review

Cancer Immunotherapy Using Bioengineered Micro/Nano Structured Hydrogels

Hydrogel systems for targeted cancer therapy

Hydrogel-based drug delivery systems for synergistic chemo/hyperthermia therapy of cancer: A comprehensive review

Hydrogel-Based Controlled Drug Delivery For Cancer Treatment: A Review

Liposomal drug delivery systems for organ-specific cancer targeting: early promises, subsequent problems, and recent breakthroughs

Cerasomes And Bicelles: Hybrid Bilayered Nanostructures With Silica-Like Surface In Cancer Theranostics

Microfluidics-mediated Liposomal Nanoparticles for Cancer Therapy: Recent Developments on Advanced Devices and Technologies

Nanocomposite Hydrogels: A Promising Approach for Developing Stimuli-responsive Platforms and their Application in Targeted Drug Delivery

Peptide-Hydrogel Nanocomposites for Anti-Cancer Drug Delivery

Recent Advances Synergistic of GQD-Based Hydrogel for Bioimaging and Drug Delivery in Cancer Treatment

Innovative theranostic hydrogels for targeted gastrointestinal cancer treatment

Hydrogel-By-Design: Smart Delivery System for Cancer Immunotherapy

Application of Hydrogels as Carrier in Tumor Therapy: A Review